De Novo device
Given Diagnostic System
Given Imaging , Ltd. · System, Imaging, Gastrointestinal, Wireless, Capsule (NEZ, Class II) · First FDA decision Aug 1, 2001, newest May 8, 2006Gastrointestinal bleedingInflammatory bowel disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
De Novo pathway
Device trials
3,044
Naming "Given"
MAUDE reports
0
Brand "Given", since 2015
PubMed studies
1,167,665
Mentioning "Given"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Given Diagnostic System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 6 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Wireless Capsule EndoscopyLocal determinationIn effectL36427Palmetto GBAUpdated Oct 22, 2021
- Wireless Gastrointestinal Motility Monitoring SystemsLocal determinationIn effectL33455Palmetto GBAUpdated Sep 3, 2021
- Wireless Capsule EndoscopyLocal determinationIn effectL33774First Coast Service Options, Inc.Updated Dec 6, 2019
- Wireless Capsule EndoscopyLocal determinationIn effectL35089Novitas Solutions, Inc.Updated Nov 15, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Given", any status and sponsor, newest update first.
- Feasibility of the Maastro Applicator in Rectal CancerActive, not recruiting
Maastricht Radiation OncologyAcademic, hospital or other
NCT06087718 · 10 participants (planned) · Start Aug 27, 2024 · Primary completion Oct 6, 2025
Device: Maastro applicator · For: Rectal Cancer; Feasibility; Toxicity and 5 more
Sites: Maastricht, Netherlands
Universitas IndonesiaAcademic, hospital or other
NCT06436222 · 60 participants · Start May 20, 2024 · Primary completion Dec 31, 2024
Device: HVNI · For: Respiratory Distress, Newborn
Sites: Jakarta Pusat, Indonesia
- T-Cell Therapy Using CD7 Negative T-Cells Expressing CD7 CAR Expressed In Pediatric Patients With Hematological Malignancies.Not yet recruiting
St. Jude Children's Research HospitalAcademic, hospital or other
NCT07941531 · 32 participants (planned) · Start Dec 2026 · Primary completion Dec 2032
Device: CliniMACS · For: Lymphoma; AML; T-ALL and 1 more
Sites: Memphis, Tennessee
3,041 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Given", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NEZ
649 reports: 232 malfunction, 397 injury, 17 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Given"[tiab]. The summary above synthesizes these.
- Erratum.
J Bone Joint Surg Am · 2016Published Erratum
- Erratum.
Int Arch Allergy Immunol · 2026Published Erratum
- Test-indication curves.
Bernstein J · Med Decis Making · 1997Research Support, Non-U.S. Gov't
- Glycopyrrolate in children.
Warran P, Radford P, Manford ML · Br J Anaesth · 1981Clinical Trial, Comparative Study
- Gas lasers.
Bloom AL · Appl Opt · 1966
- [Not Available].
Erzinger FL, Carneiro MB · J Vasc Bras · 2016
- [Not Available].
Roberge R, Bellerose N, Côté L · Can Fam Physician · 1987English Abstract
- What Is Given in Experience: The Phenomenological Account.
Lingis A · Qual Health Res · 2017
- Emotions Represent Evaluative Properties Unconsciously.
Bonard C · Erkenntnis · 2025
- Define 'learning disabilities'.
Owen M · Nurs Stand · 2017
- Metamaterial lens design.
Gutiérrez CE, Stachura E · J Opt Soc Am A Opt Image Sci Vis · 2016
- Attributable fractions for sufficient cause interactions.
VanderWeele TJ · Int J Biostat · 2010Research Support, N.I.H., Extramural
Other devices of this type
Also filed under product code NEZ.
- MiroCam® Capsule Endoscope SystemIntromedic Co., Ltd. · 510(k) 2026
- CapsoCam Plus (SV-3) Capsule Endoscopy SystemCapsoVision, Inc. · 510(k) 2024
- Olympus Small Intestinal Capsule Endoscope SystemOlympus Medical Systems Corp. · 510(k) 2019
- Given Pillcam Platform with Rapid 6.5 / Given Pillcam Platform with Pillcam Eso 3 CapsulesGiven Imaging , Ltd. · 510(k) 2011
- Modification to Given Diagnostic SystemGiven Imaging , Ltd. · 510(k) 2006
- PillCam SB 3 capsule endoscopy system, PillCam Software 9.0EGiven Imaging Ltd. (Medtronic) · 510(k) 2023
- CE Deliver (DLV)CapsoVision, Inc. · 510(k) 2025
- PillCam Genius SB System with PillCam Software v9.7 and PillCam Cloud Reader SoftwareGiven Imaging Ltd. (D.B.A. Medtronic) · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.